Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

Back to Item »

Insights

Biopharma venture capital (VC) activity is poised for one of its strongest years if the dollar volume of deals ...

Forward this item to a colleague:


(Separate multiple addresses by commas)